Ipca Laboratories (IPCALAB.NS) Financial Analysis & Valuation | Quarter Chart

Ipca Laboratories (IPCALAB.NS)

IPCALAB.NS
Price: $16.4
Fair Value: 🔒
🔒score
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides gene... more
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceut... more
Description Shares
Market Cap$4.16BExchangeNSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryINCEOPranay Premchand Godha
IPO Date1996-01-01CAGR0.14%
Employees17,335Websitewww.ipca.com
Div. Yield0.25%Payout Ratio0.06%
Buy Back Yield—Total Yield0.25%
IPCALAB.NS chart loading...
Fundamentals Technicals
Enterprise Value$359.94BP/E Ratio43.9
Forward P/E23.57PEG Ratio1.8
P/S Ratio4.17P/B Ratio5.34
P/CF Ratio50.82P/FCF Ratio124.45
EPS$0.37EPS Growth 1Y24.69%
EPS Growth 3Y73.32%EPS Growth 5Y-14.62%
Revenue Growth 1Y8.93%Gross Margin0.6%
Operating Margin0.26%Profit Margin0.1%
ROE0.12%ROA0.07%
ROCE0.26%Current Ratio2.46
Quick Ratio1.47Cash Ratio0.08
Debt/Equity0.17Interest Coverage32.13
Altman Z Score8.57Piotroski Score6

View Ipca Laboratories financial charts →